Private Advisor Group’s Immunic IMUX Stock Holding History

Private Advisor Group’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1K	Hold	1,000	–	–	﹤0.01%	2638
2025 Q4	$5.34K	Hold	1,000	–	–	﹤0.01%	2582
2025 Q3	$8.82K	Hold	1,000	–	–	﹤0.01%	2511
2025 Q2	$6.98K	Hold	1,000	–	–	﹤0.01%	2422
2025 Q1	$10.9K	Hold	1,000	–	–	﹤0.01%	2284
2024 Q4	$10K	Hold	1,000	–	–	﹤0.01%	2253
2024 Q3	$16.5K	Hold	1,000	–	–	﹤0.01%	2380
2024 Q2	$11.1K	Hold	1,000	–	–	﹤0.01%	2313
2024 Q1	$13.2K	Hold	1,000	–	–	﹤0.01%	2276
2023 Q4	$15K	Buy	+1,000	New	+$12.3K	﹤0.01%	2200

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Private Advisor Group's IMUX Position: Q1 2026 in Review

Private Advisor Group held its Immunic (IMUX) position steady in Q1 2026 at 1,000 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

Private Advisor Group first reported a position in IMUX in Q4 2023 and has held it in 10 quarters since. The position peaked at $16.5K in Q3 2024. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Private Advisor Group held 1,000 shares of Immunic worth $11.1K as of Q1 2026.
Private Advisor Group left its Immunic share count unchanged in Q1 2026.
Immunic made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2638 holding.
Private Advisor Group first reported a position in Immunic in Q4 2023 and has held it in 10 quarters since.
Private Advisor Group's Immunic position peaked at $16.5K in Q3 2024.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.